EP Patent

EP0730494A1 — Particles for binding monovalent cations and their use

Assigned to Salternate BV · Expires 1996-09-11 · 30y expired

What this patent protects

The present invention relates to particles for binding monovalent cations, in particular microcapsules, comprising a) a nucleus containing a cation exchanging material and applied thereon; b) a coating comprising a membrane being permeable for monovalent cations, in particular so…

USPTO Abstract

The present invention relates to particles for binding monovalent cations, in particular microcapsules, comprising a) a nucleus containing a cation exchanging material and applied thereon; b) a coating comprising a membrane being permeable for monovalent cations, in particular sodium, potassium, ammonium and hydrogen ions, wherein said membrane is essentially not disintegrated during passage through the intestinal tract of humans or animals. The invention further relates to the use of such particles for preparing monovalent cations containing foodstuff and/or monovalent cations containing food additives destined to be consumed by humans or animals or for preparing pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP0730494A1
Jurisdiction
EP
Classification
Expires
1996-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Salternate BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.